Search Results
Keyword:IC
South Korea Raises 2040 Electricity Demand Forecast, Increment Equivalent to 19 Large Nuclear Power Units
A forum on the formulation of South Korea's 12th Basic Plan for Electricity Supply and Demand was held in Seoul on August 20. The new round of electricity demand forecasts submitted at the meeting showed that by 2040, South Korea's annual maximum electricity demand is expected to reach 158.4 GW to 165.0 GW, an upward revision of 26.6 GW to 26.8 GW compared to the forecast proposed in April this year. Based on the 1.4 GW single-unit capacity of the AP1400 large nuclear power unit under construction in South Korea, the increment in electricity demand from this upward revision is equivalent to the electricity provided by approximately 19 large nuclear power units operating at full power. The previous April forecast for the 2040 annual maximum electricity demand was 131.8 GW to 138.2 GW. The new forecast reflects semiconductor industry clusters...
2026-08-21
Grossi's Visit to Zaporizhzhia Nuclear Power Plant Postponed
Chernichuk, the head of Russia's Zaporizhzhia Nuclear Power Plant, stated that the visit by International Atomic Energy Agency (IAEA) Director General Grossi to the Zaporizhzhia Nuclear Power Plant has been postponed, with a new date yet to be determined. Chernichuk noted that, to his understanding, the visit will be rescheduled for a later time, but the specific timing remains unclear. On August 18, Russian Foreign Ministry spokesperson Zakharova stated that the Ukrainian side had affected Grossi's planned visit to the Zaporizhzhia Nuclear Power Plant and the city of Energodar, originally scheduled for August 20-21. The trip was originally planned to coincide with the routine rotation of the IAEA expert team stationed at the Zaporizhzhia Nuclear Power Plant...
2026-08-21
Atom High-Tech and CNNC Headway Visit Tsinghua University for Business Cooperation Exchange
On August 17, Luo Xu, General Manager of Atom High-Tech, and Liu Wen, Chairman of CNNC Headway, led a delegation to Tsinghua University for a business cooperation exchange with the School of Biomedical Engineering. Hu Ye, Dean of the School of Biomedical Engineering, and Ma Kai, Associate Professor of the School, attended the exchange. The visit aimed to leverage the research and talent advantages of a top-tier university, promote deep integration of industry, academia, and research, and jointly explore new cooperation opportunities in the fields of nuclear medicine and biomedical engineering. During the exchange meeting, Atom High-Tech and CNNC Headway respectively introduced their corporate development histories, core business layouts, and future strategic plans. Subsequently, Dean Hu Ye and Associate Professor Ma Kai respectively introduced...
2026-08-21
Brazilian CancerThera Delegation Visits Uruguay's CUDIM to Advance Theranostics Cooperation in Oncology
Following the institutional partnership established between CEPID CancerThera and the Uruguayan Center for Molecular Imaging (CUDIM) in February this year, a Brazilian delegation visited Montevideo, Uruguay, from July 27 to 29 to advance the transformation of the memorandum of understanding into a concrete work plan. The visit focused on multicenter clinical trials, preclinical research, theranostics in oncology, and educational cooperation. During the visit, Brazilian researchers held working meetings with the CUDIM team, covering multiple aspects of oncology research development. CUDIM was represented by its General Director Alarico Rodriguez, as well as radiopharmacist and Technical Director of Radiopharmacy, Dr. Eduardo Osvaldo Savio Queve...
2026-08-20
Mellifluous Fusion and Advaiya Solutions Partner to Deliver AI and Business Technology Solutions for the Fusion Energy Industry
On August 19, Mellifluous Fusion, a fusion energy marketing company, signed a cooperation agreement with Advaiya Solutions, a business technology company, to provide solutions related to business applications, artificial intelligence development, and deployment for the rapidly growing fusion energy industry. Under the agreement, the collaboration will focus on enhancing operational efficiency, organizational coordination, and responsiveness in the fusion energy supply chain through integrated systems and AI tools. As fusion energy companies, suppliers, and supporting service systems expand rapidly, digital business systems and AI applications are seen as key to supporting the industry's large-scale development...
2026-08-20
Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Radiopharmaceutical Development for Solid Tumors
Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...
2026-08-20
Automatic Radiation Environment Monitoring Station in Mianyang, Sichuan Put into Trial Operation, with Core Equipment and Systems Achieving Domestic Localization
Recently, the automatic radiation environment monitoring station located within the Nuclear Medical Health Industrial Park of the China (Mianyang) Science and Technology City was officially put into trial operation. As the first automatic radiation environment monitoring station in Sichuan Province to fully achieve domestic localization of core equipment and systems, it will provide radiation environment safety assurance for the development of the nuclear medical industry in the park through 24-hour uninterrupted automatic monitoring capabilities. At the automatic radiation environment monitoring station, operational data from equipment such as environmental γ dose rate monitors are updated in real time on monitoring screens. Compared with the previous approach that relied on manual on-site sampling and batch laboratory analysis, the automatic station enables continuous monitoring, reducing the time required to produce monitoring results from several days to the same day, thereby improving...
2026-08-20
Full-Life Technologies Completes Construction of Belgian Radiopharmaceutical Production Facility and Initiates Accelerator Commissioning
Full-Life Technologies (hereinafter referred to as "Full-Life"), a privately held, fully integrated, clinical-stage international radiopharmaceutical therapy company, announced on August 20 that its radiopharmaceutical production facility in Gembloux, Belgium, has completed construction and received authorization to commence accelerator commissioning and enter the initial ramp-up phase. (Full-Life Technologies Belgium Radiopharmaceutical Production Facility) This milestone marks a significant step forward in Full-Life's vertically integrated radioisotope production capabilities moving toward formal operational status. With the completion of facility construction, the company has entered the next phase of operational preparation, including accelerator installation, phased commissioning, and validation of critical safety and operational systems.
2026-08-20
Berkeley Lab Leads Development of Portable Active-Source Muon Imager
The U.S. Department of Energy's Lawrence Berkeley National Laboratory and Ideon Technologies have received funding from the DOE's Advanced Research Projects Agency-Energy (ARPA-E) to jointly develop a field-deployable active-source muon imaging technology through the Reliable Ore Characterization Using Cornerstone Sensing Technologies (ROCKS) program. The three-year project aims to enhance the detection and characterization of underground critical mineral resources. Image credit: Lawrence Berkeley National Laboratory. Muons are subatomic particles with strong penetrating capability. Previously, Ideon Technologies has used passive muons produced by cosmic rays in the atmosphere for ore body imaging in the mining sector, mapping mineral deposits and analyzing subsurface structures. However, passive muons primarily arrive from above, limiting detection angles; additionally, the natural flux is low—approximately one per square centimeter per minute—and imaging often requires days, weeks, or even months.
2026-08-20
Korean Research Team Reveals Mechanism Behind Neutron Irradiation-Induced Reliability Degradation in Ferroelectric AI Semiconductors
Jeonbuk National University announced on the 20th that a research team led by Professor Bae Hak-yeol from the Department of Electronic Engineering at its College of Engineering, in collaboration with Professor Kim Tae-wan's team at Seoul National University and Q-Beam Solution, a startup affiliated with the Korea Atomic Energy Research Institute, conducted a joint study analyzing the causes of performance degradation in next-generation ferroelectric memory and neuromorphic semiconductor devices under neutron irradiation. The findings have been published in the latest issue of ACS Applied Electronic Materials. Ferroelectric semiconductors, which can maintain their polarization state even after power is disconnected, are considered a key candidate for next-generation non-volatile memory and neuromorphic computing devices. Neuromorphic computing aims to simultaneously implement both memory and computation within a single device...
2026-08-20
Second Radiotherapy Linear Accelerator Commissioned at Buchholz Hospital in Germany
The second medical linear accelerator for cancer radiotherapy at Buchholz Hospital in the North Heath region of Germany has been commissioned. The device was activated by the hospital's radiotherapy department under the direction of Chief Physician Dr. Günter Bohlen, marking a further enhancement of local oncological radiotherapy capabilities. The management of Buchholz Hospital and Winsen Hospital, Dr. Franziska von Brunnig (third from right) and Dr. Martin Meyer (first from right), together with Chief Physician Dr. Günter Bohlen (second from right) and the radiotherapy team, posed for a photo at the official commissioning ceremony of the second linear accelerator at Buchholz Hospital. Photo: Buchholz-Winsen Hospital. According to available information, Buchholz Hospital...
2026-08-20
Yonsei Cancer Hospital in South Korea Expands Heavy Ion Radiotherapy Indications, Three Systems Operating Simultaneously
Yonsei Cancer Hospital in South Korea recently announced that it has further expanded the indications for heavy ion radiotherapy to include head and neck cancer, sarcoma, and recurrent rectal cancer. Since becoming the first hospital in South Korea to perform heavy ion radiotherapy for prostate cancer in 2023, the hospital has gradually expanded its treatment scope to cover pancreatic cancer, liver cancer, lung cancer, and other cancer types. Medical staff, including Proton Therapy Center Director Kim Woong-sub (left), are preparing for proton therapy. (Photo provided by Yonsei University Medical Center) Meanwhile, the hospital's second rotating heavy ion radiotherapy system has been fully commissioned. This brings the hospital to a configuration of one fixed-beam system and two rotating systems operating simultaneously. The hospital...
2026-08-20
Amentum Joins Babcock UK Defense Engineering Services Framework to Support Naval Nuclear Infrastructure Projects
Amentum recently announced that it has joined Babcock International Group's five-year engineering services framework, which will support projects related to nuclear energy, marine, land, aviation, and mission systems for the UK Armed Forces both domestically and overseas. The framework aims to establish closer, longer-term partnerships with key suppliers, delivering specialist engineering capabilities to critical defense programs in a more streamlined and consistent manner. Through this arrangement, suppliers can engage in multiple projects more quickly, helping to optimize procurement processes and enhance project collaboration. According to reports, this framework agreement builds on Amentum's long-standing support for Babcock-related infrastructure, involving facilities such as HMNB Devonport...
2026-08-20
Wisconsin Electric Power Company signs 20-year power purchase agreement with NextEra for Point Beach nuclear plant
WEC Energy Group said its subsidiary Wisconsin Electric Power Company has signed a 20-year power purchase agreement with NextEra Energy Point Beach to purchase 86% of the capacity, energy, ancillary services, and environmental attributes from both units of the Point Beach Nuclear Plant in Manitowoc County, Wisconsin. According to a filing submitted to the U.S. Securities and Exchange Commission (SEC), the new agreement remains subject to approval by the Public Service Commission of Wisconsin (PSC). If approved...
2026-08-20
Princeton Plasma Physics Laboratory to Validate Spherical Tokamak Fusion Path with NSTX-U
The Princeton Plasma Physics Laboratory (PPPL) is advancing research on the National Spherical Torus Experiment-Upgrade (NSTX-U), planning to use this largest spherical tokamak in the United States to assess the potential of compact tokamak configurations for future fusion power plants. The device is designed to become one of the most powerful spherical tokamaks in the world and will be used to study key issues such as high-temperature plasma confinement, heat transport, material performance, and real-time control. The image above shows the vacuum vessel and center column of the NSTX-U at the Princeton Plasma Physics Laboratory (PPPL). This device will help scientists determine the optimal shape for future fusion power plants...
2026-08-20